Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.
about
Surface Proteoglycans as Mediators in Bacterial Pathogens InfectionsExpanding glycosaminoglycan chemical space: towards the creation of sulfated analogs, novel polymers and chimeric constructs.Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains.Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion.Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparinUncovering the Catalytic Direction of Chondroitin AC Exolyase: FROM THE REDUCING END TOWARDS THE NON-REDUCING ENDLow-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.A Dilemma in the Glycosaminoglycan-Based Therapy: Synthetic or Naturally Unique Molecules?A novel method to identify hub pathways of rheumatoid arthritis based on differential pathway networks.Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide.Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.
P2860
Q26768544-6A3B5FB6-0261-44B7-92A0-ED5F0CE3874DQ33762922-24193C45-7D74-4B3C-ADB7-8B11C501ACC9Q34616858-9261E046-04BF-4BAE-A436-7390DA903E44Q35803331-71DF69BF-490F-4096-A27B-3A33E9330927Q36015630-2664D27C-B4CB-48FC-9763-23546F6985DAQ36744482-6EF40B35-FADC-404F-B560-98ECBC16B466Q37651351-F19DD6A7-E0E2-492B-B7CB-93C5D5DDF63EQ38116039-544F4970-9AD8-4A67-8D25-4FC2E17E11E6Q38543731-1C935927-4F6F-4A64-AB39-549FB0508BB8Q38656697-DA9BB719-178A-4B08-8A9B-68FBF373A0B9Q47310898-16B1FC8A-5F9D-4E84-899F-058F6152B57DQ47370006-09BF6F54-2674-4893-8B5B-DEC518992F01Q47379826-E1D33D05-0125-49EB-9CD4-B7E09BBAAEF1
P2860
Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heparosan-derived heparan sulf ...... potential therapeutic agents.
@en
type
label
Heparosan-derived heparan sulf ...... potential therapeutic agents.
@en
prefLabel
Heparosan-derived heparan sulf ...... potential therapeutic agents.
@en
P2093
P2860
P356
P1476
Heparosan-derived heparan sulf ...... potential therapeutic agents.
@en
P2093
Fengshan Wang
Juzheng Sheng
Yuhong Liu
P2860
P304
P356
10.1002/MED.21263
P577
2012-04-11T00:00:00Z